Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | -2.18% | +2.25% | -33.25% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.25% | 365M | |
+49.64% | 54.63B | |
-4.63% | 39.92B | |
+37.77% | 38.82B | |
+16.16% | 26.86B | |
-12.56% | 26.22B | |
-21.46% | 18.78B | |
+25.71% | 12.21B | |
+2.31% | 12.16B | |
+27.14% | 11.94B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Organogenesis : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $13 From $9, Maintains Outperform Rating